Extract notice to the Minister

Stoboclo (ostéoporose)

Common name / Subject : denosumab (biosimilaire)
Name of the manufacturer : Celltrion
Form : Sol. Inj. S.C. (ser)
Dosage : 60 mg/ml (1 ml)

Indication : Ostéoporose

INESSS' Recommendation
Inscription - Sous conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception (2025-11-06)

Evaluation published on November 06, 2025

INESSSid: 24446
Recevable on September 09, 2024

Download Advice to minister about Stoboclo (ostéoporose)

Extrait d'avis au ministre sur Stoboclo 342 KiO

Subscribe to our newsletter now

Subscription